Day One Biopharmaceuticals Inc.(DAWN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DAWN Day One Biopharmaceuticals Inc.

盘前交易 01-20 05:03:06 EST

10.16

-0.34

-3.24%

最高10.90	最低10.10	成交量416.92万
今开10.56	昨收10.50	日振幅7.67%
总市值10.43亿	流通市值8.00亿	总股本1.03亿
成交额4,310万	换手率5.29%	流通股本7,877万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"DAWN","market":"US","secType":"STK","nameCN":"Day One Biopharmaceuticals Inc.","latestPrice":10.16,"timestamp":1768597200000,"preClose":10.5,"halted":0,"volume":4169226,"delay":0,"changeRate":-0.032380952380952364,"floatShares":78766151,"shares":102675502,"eps":-1.474773,"marketStatus":"盘前交易","change":-0.34,"latestTime":"01-20 05:03:06 EST","open":10.56,"high":10.9,"low":10.095,"amount":43096688.793455996,"amplitude":0.076667,"askPrice":12.28,"askSize":100,"bidPrice":10.01,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.474773,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768919400000},"marketStatusCode":1,"adr":0,"listingDate":1622088000000,"exchange":"NASDAQ","adjPreClose":10.16,"postHourTrading":{"tag":"盘后","latestPrice":10.25,"preClose":10.16,"latestTime":"19:51 EST","volume":28646,"amount":291976.9396,"timestamp":1768611098804,"change":0.09,"changeRate":0.008858,"amplitude":0.020984},"volumeRatio":1.1119821328610542,"impliedVol":0.6465,"impliedVolPercentile":0.256},"requestUrl":"/m/hq/s/DAWN","defaultTab":"news","newsList":[{"id":"1198566131","title":"Day One公布2025年Ojemda™净产品收入初步预测 并提供2026年净产品收入指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1198566131","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198566131?lang=zh_cn&edition=full","pubTime":"2026-01-12 06:00","pubTimestamp":1768168815,"startTime":"0","endTime":"0","summary":"生物制药公司Day One Biopharmaceuticals Inc.（以下简称Day One）今日公布了其核心产品Ojemda™在2025年的初步净产品收入预测，同时向市场提供了针对2026年的净产品收入指引。这一举措旨在向投资者和业界清晰展示公司对其重磅疗法未来商业表现的信心与预期。\nOjemda™作为公司研发管线中的关键资产，其收入预测是衡量公司未来增长潜力的重要指标。此次公布的指引不仅反映了市场对该产品的需求预期，也体现了公司在商业化执行方面的战略规划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DAWN","BK4139","BK4539"],"gpt_icon":0},{"id":"2593451473","title":"Day One Biopharmaceuticals, Inc.盘中异动 股价大涨5.09%报9.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593451473","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593451473?lang=zh_cn&edition=full","pubTime":"2025-12-23 00:01","pubTimestamp":1766419267,"startTime":"0","endTime":"0","summary":"北京时间2025年12月23日00时01分，Day One Biopharmaceuticals, Inc.股票出现波动，股价大幅上涨5.09%。Day One Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Day One Biopharmaceuticals, Inc.公司简介：Day One Biopharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发和商业化针对所有年龄段遗传性癌症患者的靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122300010897a08eb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122300010897a08eb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","DAWN"],"gpt_icon":0},{"id":"2592900091","title":"DePIN 项目 DAWN 完成 1300 万美元 B 轮融资，Polychain 领投","url":"https://stock-news.laohu8.com/highlight/detail?id=2592900091","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592900091?lang=zh_cn&edition=full","pubTime":"2025-12-18 23:42","pubTimestamp":1766072520,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据官方消息，去中心化自治无线网络项目 DAWN 宣布完成 1,300 万美元 B 轮融资，Polychain 领投。\n\n新资金将用于加速全球扩张、新部署和生态系统合作，DAWN 将继续致力于在全球范围内扩展去中心化宽带。 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2230862","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","DAWN"],"gpt_icon":0},{"id":"2592947726","title":"Day One Biopharmaceuticals, Inc.盘中异动 下午盘股价大涨5.15%报8.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592947726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592947726?lang=zh_cn&edition=full","pubTime":"2025-12-18 02:09","pubTimestamp":1765994972,"startTime":"0","endTime":"0","summary":"北京时间2025年12月18日02时09分，Day One Biopharmaceuticals, Inc.股票出现波动，股价大幅拉升5.15%。Day One Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Day One Biopharmaceuticals, Inc.公司简介：Day One Biopharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发和商业化针对所有年龄段遗传性癌症患者的靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121802093297a06f8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121802093297a06f8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DAWN","BK4139","BK4539"],"gpt_icon":0},{"id":"2586041502","title":"Day One Biopharmaceuticals, Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586041502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586041502?lang=zh_cn&edition=full","pubTime":"2025-11-25 01:07","pubTimestamp":1764004041,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日01时07分，Day One Biopharmaceuticals, Inc.股票出现异动，股价快速拉升5.05%。Day One Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Day One Biopharmaceuticals, Inc.公司简介：Day One Biopharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发和商业化针对所有年龄段遗传性癌症患者的靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125010722a70ebf03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125010722a70ebf03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DAWN","BK4139","BK4539"],"gpt_icon":0},{"id":"1161794390","title":"Day One公布Ojemda™ (Tovorafenib)第二阶段Firefly-1试验三年随访数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1161794390","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161794390?lang=zh_cn&edition=full","pubTime":"2025-11-24 21:01","pubTimestamp":1763989301,"startTime":"0","endTime":"0","summary":"Day One公布Ojemda™ (Tovorafenib)第二阶段Firefly-1试验三年随访数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DAWN","BK4539"],"gpt_icon":0},{"id":"1106872514","title":"Day One生物制药收购Mersana Therapeutics，以推进为各年龄段面临生命威胁疾病的人们带来新药的使命","url":"https://stock-news.laohu8.com/highlight/detail?id=1106872514","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106872514?lang=zh_cn&edition=full","pubTime":"2025-11-13 19:03","pubTimestamp":1763031797,"startTime":"0","endTime":"0","summary":"Day One生物制药收购Mersana Therapeutics，以推进为各年龄段面临生命威胁疾病的人们带来新药的使命","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DAWN","BK4139","BK4539"],"gpt_icon":0},{"id":"1173463873","title":"异动解读 | Day One生物制药盘中大涨5.04%，新药Ojemda™数据将在神经肿瘤学会年会报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1173463873","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173463873?lang=zh_cn&edition=full","pubTime":"2025-11-10 23:51","pubTimestamp":1762789906,"startTime":"0","endTime":"0","summary":"Day One生物制药今日盘中大涨5.04%，引起投资者广泛关注。这一显著涨幅与公司最新发布的重要研究数据密切相关。据悉，Day One生物制药将在即将召开的2025年神经肿瘤学会年会上，通过口头报告形式公布其重磅新药Ojemda的最新数据。Ojemda是Day One的主打产品，其在神经肿瘤治疗领域的潜力备受市场期待。此次Ojemda数据被选为口头报告，表明其研究结果可能具有重要意义。投资者对这一潜在的突破性进展反应积极，推动Day One生物制药股价在盘中显著上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DAWN"],"gpt_icon":0},{"id":"1105795532","title":"异动解读 | Day One生物制药公司盘中大涨5.04%，新Ojemda™数据公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1105795532","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105795532?lang=zh_cn&edition=full","pubTime":"2025-11-10 23:51","pubTimestamp":1762789903,"startTime":"0","endTime":"0","summary":"Day One生物制药公司在周一盘中大涨5.04%，引起了投资者的广泛关注。此次股价上涨主要受益于公司发布的最新消息。Day One生物制药公司宣布将在2025年神经肿瘤学会年会上公布其重要产品Ojemda 的最新数据，并将进行口头报告。投资者对这一消息反应积极，认为这可能会增强公司的市场竞争力，并有望带来可观的经济效益。这一积极信号推动了Day One生物制药公司股价的显著上涨。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DAWN"],"gpt_icon":0},{"id":"1158912236","title":"Day One公布新Ojemda™ (Tovorafenib)数据，将在2025年神经肿瘤学会年会上进行口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1158912236","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158912236?lang=zh_cn&edition=full","pubTime":"2025-11-10 20:01","pubTimestamp":1762776089,"startTime":"0","endTime":"0","summary":"Day One公布新Ojemda™ (Tovorafenib)数据，将在2025年神经肿瘤学会年会上进行口头报告","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DAWN","BK4539"],"gpt_icon":0},{"id":"1143245316","title":"Day One Biopharmaceuticals Inc. 上调2025年Ojemda全年净产品收入指引至1.45亿至1.5亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143245316","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143245316?lang=zh_cn&edition=full","pubTime":"2025-11-05 05:25","pubTimestamp":1762291555,"startTime":"0","endTime":"0","summary":"Day One Biopharmaceuticals Inc. 上调2025年Ojemda全年净产品收入指引至1.45亿至1.5亿美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DAWN","BK4539"],"gpt_icon":0},{"id":"2576058912","title":"Day One Biopharmaceuticals, Inc.盘中异动 下午盘快速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576058912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576058912?lang=zh_cn&edition=full","pubTime":"2025-10-17 03:24","pubTimestamp":1760642690,"startTime":"0","endTime":"0","summary":"北京时间2025年10月17日03时24分，Day One Biopharmaceuticals, Inc.股票出现波动，股价急速下跌5.01%。Day One Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Day One Biopharmaceuticals, Inc.公司简介：Day One Biopharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发和商业化针对所有年龄段遗传性癌症患者的靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017032451a6bd8033&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251017032451a6bd8033&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","DAWN","BK4539"],"gpt_icon":0},{"id":"2568211928","title":"Day One Biopharmaceuticals, Inc.盘中异动 临近收盘大幅下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568211928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568211928?lang=zh_cn&edition=full","pubTime":"2025-09-20 03:55","pubTimestamp":1758311732,"startTime":"0","endTime":"0","summary":"北京时间2025年09月20日03时55分，Day One Biopharmaceuticals, Inc.股票出现异动，股价快速下挫5.13%。Day One Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。Day One Biopharmaceuticals, Inc.公司简介：Day One Biopharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发和商业化针对所有年龄段遗传性癌症患者的靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920035533979db199&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920035533979db199&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DAWN","BK4139","BK4539"],"gpt_icon":0},{"id":"2558817836","title":"Day One Biopharmaceuticals, Inc.2025财年第二财季实现净利润-30.32百万美元，同比减少587.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558817836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558817836?lang=zh_cn&edition=full","pubTime":"2025-08-11 00:01","pubTimestamp":1754841694,"startTime":"0","endTime":"0","summary":"8月11日，Day One Biopharmaceuticals, Inc.公布财报，公告显示公司2025财年第二财季净利润为-30.32百万美元，同比减少587.53%；其中营业收入为33.91百万美元，同比增加314.04%，每股基本收益为-0.29美元。从资产负债表来看，Day One Biopharmaceuticals, Inc.总负债58.20百万美元，其中短期债务153000.00美元，资产负债比为0.09，流动比率为0.10。机构评级：截至2025年8月11日，当前有8家机构对Day One Biopharmaceuticals, Inc.目标价做出预测，其中目标均价为23.75美元，其中最低目标价为16.00美元，最高目标价为34.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000344a480578a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000344a480578a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DAWN"],"gpt_icon":0},{"id":"1119213737","title":"异动解读 | Day One生物制药财报喜忧参半，股价盘中大跌14.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=1119213737","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119213737?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:15","pubTimestamp":1754489748,"startTime":"0","endTime":"0","summary":"生物制药公司Day One Biopharmaceuticals今日盘中大跌14.75%，引发市场广泛关注。这一显著跌幅紧随公司发布的最新季度财报，财报结果喜忧参半，导致投资者信心受挫。根据公司公布的截至6月30日的季度业绩报告，Day One Biopharmaceuticals的调整后每股亏损为0.29美元，优于分析师平均预期的0.36美元亏损。值得注意的是，Day One Biopharmaceuticals今年迄今股价已下跌46.8%，这次的财报可能进一步打击了投资者信心。投资者将密切关注公司未来的业绩表现，以评估其长期发展前景。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DAWN"],"gpt_icon":0},{"id":"1159165117","title":"异动解读 | 财报喜忧参半，Day One Biopharmaceuticals盘前暴跌14.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=1159165117","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159165117?lang=zh_cn&edition=full","pubTime":"2025-08-06 17:02","pubTimestamp":1754470942,"startTime":"0","endTime":"0","summary":"生物制药公司Day One Biopharmaceuticals周三盘前股价大跌14.24%，引发市场广泛关注。这一显著跌幅紧随公司发布的最新季度财报，其中包含了一些喜忧参半的业绩数据。根据公司公布的截至6月30日的季度业绩报告，Day One Biopharmaceuticals的调整后每股亏损为0.29美元，优于分析师平均预期的0.36美元亏损。值得注意的是，Day One Biopharmaceuticals今年迄今股价已下跌46.8%，这次的财报可能进一步打击了投资者信心。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DAWN"],"gpt_icon":0},{"id":"1154717628","title":"异动解读 | Day One生物制药季报营收不及预期，股价盘前暴跌14.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=1154717628","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154717628?lang=zh_cn&edition=full","pubTime":"2025-08-06 17:02","pubTimestamp":1754470942,"startTime":"0","endTime":"0","summary":"生物制药公司Day One Biopharmaceuticals今日盘前股价大跌14.24%，引发市场广泛关注。这一显著跌幅紧随公司发布的最新季度财报，财报结果喜忧参半，导致投资者信心受挫。根据公司公布的截至6月30日的季度业绩报告，Day One Biopharmaceuticals的调整后每股亏损为0.29美元，优于分析师平均预期的0.36美元亏损。值得注意的是，Day One Biopharmaceuticals今年迄今股价已下跌46.8%，这次的财报可能进一步打击了投资者信心。投资者将密切关注公司未来的业绩表现，以评估其长期发展前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DAWN"],"gpt_icon":0},{"id":"1102419165","title":"异动解读 | Day One Biopharmaceuticals盘后暴跌14.83%，季度业绩喜忧参半","url":"https://stock-news.laohu8.com/highlight/detail?id=1102419165","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102419165?lang=zh_cn&edition=full","pubTime":"2025-08-06 05:04","pubTimestamp":1754427876,"startTime":"0","endTime":"0","summary":"生物制药公司Day One Biopharmaceuticals今日盘后股价大跌14.83%，引发市场关注。这一大幅下跌紧随公司发布的最新季度财报。根据公司公布的截至6月30日的季度业绩报告，Day One Biopharmaceuticals的调整后每股亏损为0.29美元，优于分析师平均预期的0.36美元亏损。此外，公司本季度净亏损达3032万美元。尽管每股亏损好于预期，但投资者似乎对公司的整体财务表现感到失望。值得注意的是，Day One Biopharmaceuticals今年迄今股价已下跌46.8%，这次的财报可能进一步打击了投资者信心。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DAWN"],"gpt_icon":0},{"id":"2518209168","title":"Day One Biopharmaceuticals, Inc.盘中异动 大幅下挫5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518209168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518209168?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:22","pubTimestamp":1741630936,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时22分，Day One Biopharmaceuticals, Inc.股票出现波动，股价急速下跌5.07%。Day One Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Aeon Biopharma, Inc.、Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为5964.45%、3845.46%、1004.33%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Day One Biopharmaceuticals, Inc.公司简介：Day One biopharmacics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311022216a26a9029&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311022216a26a9029&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","DAWN"],"gpt_icon":0},{"id":"2517662671","title":"Day One Biopharmaceuticals, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517662671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517662671?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:44","pubTimestamp":1741272255,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时44分，Day One Biopharmaceuticals, Inc.股票出现异动，股价快速下挫5.05%。Day One Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Plus Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Aeon Biopharma, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Aditxt, Inc.较为活跃，换手率分别为1253.87%、261.15%、58.34%，振幅较大的相关个股有Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为31.46%、30.53%、23.12%。Day One Biopharmaceuticals, Inc.公司简介：Day One biopharmacics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224415989eb765&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224415989eb765&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","DAWN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.dayonebio.com","stockEarnings":[{"period":"1week","weight":0.1365},{"period":"1month","weight":0.1598},{"period":"3month","weight":0.4111},{"period":"6month","weight":0.5875},{"period":"1year","weight":-0.1806},{"period":"ytd","weight":0.0901}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":0.0302},{"period":"3month","weight":0.041},{"period":"6month","weight":0.1021},{"period":"1year","weight":0.1691},{"period":"ytd","weight":0.0143}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Day One Biopharmaceuticals, Inc.于2018年11月在特拉华州注册成立，名称为Hero Therapeutics Holding Company，LLC。随后，公司于2018年12月更名为Day One Therapeutics Holding Company，LLC，并于2020年3月更名为Day One Biopharmaceuticals Holding Company，LLC。该公司有两家子公司：Day One Biopharmaceuticals，Inc.（以前称为Hero Therapeutics Inc.）于2018年11月在特拉华州注册成立的全资子公司，以及于2019年12月在特拉华州注册成立的多数子公司DOT Therapeutics-1，Inc.。他们是临床阶段的生物制药公司，致力于开发和商业化针对患者的靶向疗法具有基因定义的癌症的所有年龄段。该公司的主要候选产品DAY101是一种口服，脑渗透性高选择性II型pan-RAF激酶抑制剂。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.003148},{"month":2,"riseRate":0.25,"avgChangeRate":-0.095934},{"month":3,"riseRate":0,"avgChangeRate":-0.171307},{"month":4,"riseRate":0.25,"avgChangeRate":-0.049371},{"month":5,"riseRate":0.25,"avgChangeRate":-0.150324},{"month":6,"riseRate":0.6,"avgChangeRate":0.358793},{"month":7,"riseRate":0.8,"avgChangeRate":0.035671},{"month":8,"riseRate":0.8,"avgChangeRate":0.129963},{"month":9,"riseRate":0.2,"avgChangeRate":-0.087961},{"month":10,"riseRate":0.8,"avgChangeRate":0.032302},{"month":11,"riseRate":0.4,"avgChangeRate":-0.008674},{"month":12,"riseRate":0.4,"avgChangeRate":0.016669}],"exchange":"NASDAQ","name":"Day One Biopharmaceuticals Inc.","nameEN":"Day One Biopharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Day One Biopharmaceuticals Inc.(DAWN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Day One Biopharmaceuticals Inc.(DAWN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Day One Biopharmaceuticals Inc.,DAWN,Day One Biopharmaceuticals Inc.股票,Day One Biopharmaceuticals Inc.股票老虎,Day One Biopharmaceuticals Inc.股票老虎国际,Day One Biopharmaceuticals Inc.行情,Day One Biopharmaceuticals Inc.股票行情,Day One Biopharmaceuticals Inc.股价,Day One Biopharmaceuticals Inc.股市,Day One Biopharmaceuticals Inc.股票价格,Day One Biopharmaceuticals Inc.股票交易,Day One Biopharmaceuticals Inc.股票购买,Day One Biopharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Day One Biopharmaceuticals Inc.(DAWN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Day One Biopharmaceuticals Inc.(DAWN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}